Carregant...
α(1)-Antitrypsin deficiency · 6: New and emerging treatments for α(1)-antitrypsin deficiency
Alpha-1-antitrypsin (AAT) deficiency is a genetic condition that increases the risk of developing lung and liver disease, as well as other associated conditions. Most treatment of affected individuals is not specifically directed at AAT deficiency but focuses on the resultant disease state. The only...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Group
2004
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1746849/ https://ncbi.nlm.nih.gov/pubmed/15454659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thx.2003.006551 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|